T43.215D Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter

Name of the Condition

• Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter

Summary

This condition describes an adverse reaction to selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) during a subsequent encounter, meaning the patient is receiving ongoing care for the reaction. SSNRIs are a class of antidepressants used to treat depression, anxiety, and other conditions. The code is applied when the adverse effect is the focus of the encounter, and the patient has a history of the reaction.

Causes

Adverse effects occur due to the body's reaction to SSNRIs, which may include unwanted physiological or psychological responses. These reactions can arise from the medication's mechanism of action, individual sensitivity, or interactions with other substances.

Risk Factors

• Prolonged use of SSNRIs
• Pre-existing health conditions affecting drug metabolism (e.g., liver or kidney disease)
• Concurrent use of medications that interact with SSNRIs
• Genetic predisposition to adverse drug reactions

Symptoms

• Nausea, vomiting, or gastrointestinal distress
• Dizziness, drowsiness, or headache
• Sleep disturbances (insomnia or hypersomnia)
• Mood changes (e.g., anxiety, irritability)
• Sexual dysfunction
• Increased sweating or tremors

Diagnosis

Diagnosis is based on a comprehensive patient history, including medication usage and timing of symptom onset. Clinical assessment of symptoms and exclusion of other causes (e.g., unrelated illnesses or medication interactions) are key. Laboratory tests may be used to rule out alternative diagnoses but are not always required for confirmation.

Treatment Options

• Adjusting the SSNRI dose or switching to an alternative medication
• Symptomatic management (e.g., antiemetics for nausea, sleep aids for insomnia)
• Monitoring for resolution or escalation of symptoms
• Patient education on recognizing and reporting adverse effects

Prognosis and Follow-Up

Most adverse effects resolve with dose adjustment or discontinuation of the SSNRI. Follow-up care focuses on symptom resolution and ensuring the patient tolerates any new treatment. Regular monitoring may be needed to prevent recurrence.

Complications

• Worsening of underlying mental health conditions if treatment is interrupted
• Severe reactions (e.g., serotonin syndrome) in rare cases
• Non-adherence to prescribed medications due to persistent side effects

Lifestyle & Prevention

• Taking medications as prescribed and reporting side effects promptly
• Avoiding alcohol or other substances that may interact with SSNRIs
• Maintaining open communication with healthcare providers about symptom changes
• Following up on scheduled appointments to adjust treatment as needed

When to Seek Professional Help

Seek immediate medical attention if symptoms are severe (e.g., seizures, irregular heartbeat) or worsening. Contact a healthcare provider for persistent or new side effects that impact daily functioning.

Tips for Medical Coders

Use this code for a subsequent encounter where the adverse effect of SSNRIs is the focus of care. Document the specific symptoms, treatment provided, and any changes to the medication regimen. Ensure the encounter is not the initial treatment for the adverse effect (use a different code for initial encounters).